JPWO2022071601A1 - - Google Patents
Info
- Publication number
- JPWO2022071601A1 JPWO2022071601A1 JP2022554159A JP2022554159A JPWO2022071601A1 JP WO2022071601 A1 JPWO2022071601 A1 JP WO2022071601A1 JP 2022554159 A JP2022554159 A JP 2022554159A JP 2022554159 A JP2022554159 A JP 2022554159A JP WO2022071601 A1 JPWO2022071601 A1 JP WO2022071601A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020168107 | 2020-10-02 | ||
| PCT/JP2021/036525 WO2022071601A1 (ja) | 2020-10-02 | 2021-10-01 | 血中エクソソームのタンパク質マーカーを利用したcovid-19重症化予測方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022071601A1 true JPWO2022071601A1 (https=) | 2022-04-07 |
| JPWO2022071601A5 JPWO2022071601A5 (https=) | 2024-10-09 |
Family
ID=80951770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554159A Pending JPWO2022071601A1 (https=) | 2020-10-02 | 2021-10-01 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240263234A1 (https=) |
| EP (1) | EP4223887A4 (https=) |
| JP (1) | JPWO2022071601A1 (https=) |
| CN (1) | CN114556105A (https=) |
| WO (1) | WO2022071601A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023007809A1 (ja) * | 2021-07-29 | 2023-02-02 | 国立大学法人東北大学 | コロナウイルス感染症の重症化リスクの評価方法、およびコロナウイルス感染症の重症化リスク評価キット |
| CN115097147B (zh) * | 2022-08-23 | 2022-11-25 | 细胞生态海河实验室 | 预测奥密克戎复阳风险的生物标志物及代谢、蛋白、联合模型 |
| KR20250107848A (ko) | 2022-11-07 | 2025-07-14 | 아이에스엠 가부시키가이샤 | 코트머단백질 복합체 서브유닛 베타2에 대한 항체 |
| WO2024181522A1 (ja) * | 2023-02-28 | 2024-09-06 | 国立大学法人大阪大学 | Covid-19を検査する方法 |
| CN117467598B (zh) * | 2023-12-28 | 2024-05-10 | 健颐生物科技发展(山东)有限公司 | 肝细胞源pcsk9外泌体的制备方法 |
| WO2025170060A1 (ja) * | 2024-02-08 | 2025-08-14 | 学校法人慈恵大学 | 急性肺障害治療薬 |
| CN119177277B (zh) * | 2024-10-08 | 2025-05-27 | 北京医院 | 与结肠癌细胞对吉西他滨耐药性相关的circ86591的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2697653B1 (en) * | 2011-04-15 | 2016-03-30 | Children's Medical Center Corporation | Diagnostic markers and therapeutic targets of kawasaki disease |
| CN111366728A (zh) * | 2020-03-27 | 2020-07-03 | 重庆探生科技有限公司 | 一种用于检测新型冠状病毒SARS-CoV-2的免疫层析试剂盒 |
-
2021
- 2021-10-01 EP EP21816304.6A patent/EP4223887A4/en active Pending
- 2021-10-01 US US17/618,412 patent/US20240263234A1/en active Pending
- 2021-10-01 JP JP2022554159A patent/JPWO2022071601A1/ja active Pending
- 2021-10-01 WO PCT/JP2021/036525 patent/WO2022071601A1/ja not_active Ceased
- 2021-10-01 CN CN202180002820.2A patent/CN114556105A/zh active Pending
Non-Patent Citations (6)
| Title |
|---|
| AN, P. ET AL.: "Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications", PHARMACOLOGICAL RESEARCH, JPN6020034567, 23 May 2020 (2020-05-23), ISSN: 0005785563 * |
| FUJITA, YU ET AL.: "Early prediction of COVID-19 severity using extracellular vesicle COPB2", JOURNAL OF EXTRACELLULAR VESICLES, vol. 10, JPN6021049874, 2 June 2021 (2021-06-02), pages 12092, ISSN: 0005785565 * |
| LI, HUAN ET AL.: "Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis", JOURNAL OF INFECTION, vol. 80, JPN6021049875, June 2020 (2020-06-01), pages 646 - 655, ISSN: 0005785564 * |
| SKEVAKI, C., ET AL: "Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus", JOURNAL OF INFECTION, JPN6021034619, 21 June 2020 (2020-06-21), ISSN: 0005785561 * |
| WANG, C-Z. ET AL.: "Early risk factors of the exacerbation of coronavirus disease 2019 pneumonia", JOURNAL OF MEDICAL VIROLOGY, JPN6020034568, 29 May 2020 (2020-05-29), ISSN: 0005785562 * |
| 植田幸嗣ほか: "エクソソームのプロテオーム解析によるバイオマーカー開発", 医学のあゆみ, vol. 251, no. 10, JPN6021049873, 6 December 2014 (2014-12-06), pages 975 - 979, ISSN: 0005785566 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4223887A8 (en) | 2023-11-22 |
| EP4223887A1 (en) | 2023-08-09 |
| WO2022071601A1 (ja) | 2022-04-07 |
| EP4223887A4 (en) | 2024-10-30 |
| CN114556105A (zh) | 2022-05-27 |
| US20240263234A1 (en) | 2024-08-08 |
| TW202223104A (zh) | 2022-06-16 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241001 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241001 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250805 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251003 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260403 |